Evidence map›Paper›PMID 35853659›Full record

ArticlePediatric dermatology2022

Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders.

Lihi Atzmony, Nelson Ugwu, Claire Hamilton, Amy S Paller, Loren Zech, Richard J Antaya, Keith A Choate

Open access · greenAbstract read
In one paragraph

Article in Pediatric dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. [Incontinentia pigmenti-the skin never forgets].Dermatologie (Heidelberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Darier disease: Current insights and challenges in pathogenesis and management.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Review
  9. Article
  10. Article
  11. Lichen Striatus: An Updated Review.Current pediatric reviews · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. A blaschkoid birthmark.JAAD case reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Lihi AtzmonyDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-5149-5777
Nelson UgwuDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-8647-5300
Claire HamiltonHarvard Medical School, Boston, Massachusetts, USA.
Amy S PallerDepartments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0001-6187-6549
Loren ZechDepartment of Dermatology, The University of New Mexico, NE Albuquerque, New Mexico, USA.ORCID https://orcid.org/0000-0002-6846-8828
Richard J AntayaDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-8557-5986
Keith A ChoateDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.
Yale University · USHarvard University · USNorthwestern University · USTel Aviv University · ILUniversity of New Mexico · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Center for Mendelian DisordersU54HG006504 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, GUNEL, MURAT · 2012 to 2015
$11.0M
Genetics and Pathobiology of Cutaneous Mosaic DisordersR01AR071491 · NIAMS · YALE UNIVERSITY · PI KEITH A CHOATE · 2018 to 2026
$4.2M
NCATS NIH HHS UL1 TR001863NHGRI NIH HHS U54 HG006504NIAMS NIH HHS R01 AR071491NIH HHS R01 AR071491
6 · The paper itself

Abstract

backgroundInflammatory linear verrucous epidermal nevus (ILVEN) is a rare skin disease characterized by pruritic erythematous scaly plaques distributed along the lines of Blaschko. Two cases of ILVEN with CARD14 mutations and one case with a GJA1 mutation have been previously reported.

objectiveTo elucidate the genetic cause of a cohort of patients diagnosed based on clinical and histopathological evaluation with ILVEN.

methodsWe recruited patients diagnosed with ILVEN based on clinical and histopathological criteria. Exome sequencing of affected skin with or without blood/saliva was performed and germline and somatic pathogenic variants were identified.

resultsFive patients were enrolled. All had skin lesions from birth or early childhood. Two patients developed psoriasis vulgaris after the diagnosis of ILVEN. The first had a germline heterozygous CARD14 mutation and a post-zygotic hotspot mutation in KRT10. The histopathologic evaluation did not show epidermolytic hyperkeratosis. The second had a post-zygotic hotspot mutation in HRAS. Her ILVEN became itchy once psoriasis developed. One patient was re-diagnosed with linear porokeratosis based on a germline mutation in PMVK and a post-zygotic second-hit mutation. Two patients were re-diagnosed with congenital hemidysplasia with ichthyosiform nevus and limb defect nevus based on germline NSDHL mutations.

conclusionILVEN is a clinical descriptor for a heterogenous group of mosaic inflammatory disorders. Genetic analysis has the potential to more precisely categorize ILVEN and permits pathogenesis-directed therapies in some cases.

Indexed as

NevusNevus, PigmentedNevus, Sebaceous of JadassohnPsoriasisSkin DiseasesSkin Neoplasms3-Hydroxysteroid DehydrogenasesCARD Signaling Adaptor ProteinsChild, PreschoolFemaleGuanylate CyclaseHumansMembrane Proteins3-Hydroxysteroid DehydrogenasesCARD14 protein, humanCARD Signaling Adaptor ProteinsGuanylate CyclaseMembrane ProteinsNsdhl protein, humanCHILD syndromeepidermal nevusgenetic skin diseasesinflammatory linear verrucous epidermal nevusmosaicism

Identifiers

PMID35853659
PMCPMC9712156
OpenAlexW4286214521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.